Jafron Biomedical Co.,Ltd.
SZSE:300529.SZ
20.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 2,810.294 | 2,558.755 | 2,319.448 | 1,575.05 | 1,271.73 | 1,080.802 | 1,061.659 | 760.084 | 287.487 | 232.85 | 248.369 | 217.356 | 175.282 |
| Short Term Investments
| 0 | 0 | 150.015 | -20.418 | -14.819 | -3.362 | 0 | 100 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 2,810.294 | 2,558.755 | 2,469.463 | 1,575.05 | 1,271.73 | 1,080.802 | 1,061.659 | 760.084 | 287.487 | 232.85 | 248.369 | 217.356 | 175.282 |
| Net Receivables
| 0 | 239.637 | 308.055 | 215.798 | 160.664 | 137.709 | 108.873 | 81.437 | 57.316 | 37.073 | 13.061 | 3.645 | 0 |
| Inventory
| 384.996 | 349.13 | 196.546 | 120.672 | 92.314 | 61.158 | 45.238 | 50.484 | 39.01 | 35.07 | 27.269 | 24.164 | 18.315 |
| Other Current Assets
| 116.551 | 138.874 | 75.27 | 125.473 | 59.415 | 45.954 | 29.425 | 106.836 | 16.371 | 11.815 | 11.225 | 9.409 | 17.233 |
| Total Current Assets
| 3,311.842 | 3,293.248 | 3,055.652 | 1,986.611 | 1,559.744 | 1,305.242 | 1,230.659 | 999.201 | 400.185 | 310.92 | 299.924 | 254.575 | 210.83 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 1,770.517 | 1,671.903 | 1,272.529 | 905.505 | 639.629 | 457.637 | 325.547 | 273.324 | 260.164 | 201.283 | 135.032 | 66.325 | 14.729 |
| Goodwill
| 12.207 | 37.814 | 44.07 | 44.07 | 44.07 | 44.07 | 17.718 | 7.011 | 7.011 | 7.011 | 7.011 | 0 | 0 |
| Intangible Assets
| 100.367 | 100.431 | 101.313 | 89.889 | 48.051 | 46.587 | 30.912 | 17.143 | 17.474 | 16.722 | 16.138 | 16.469 | 16.594 |
| Goodwill and Intangible Assets
| 112.574 | 138.246 | 145.383 | 133.959 | 92.121 | 90.657 | 48.631 | 24.153 | 24.485 | 23.733 | 23.149 | 16.469 | 16.594 |
| Long Term Investments
| 116.129 | 69.445 | -38.81 | 119.405 | 115.609 | 93.928 | 3.456 | 0.853 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 30.346 | 33.36 | 26.545 | 12.972 | 10.069 | 7.138 | 2.022 | 1.1 | 0.824 | 0.484 | 0.207 | 0.161 | 0.125 |
| Other Non-Current Assets
| 201.894 | 207.214 | 348.803 | 58.218 | 77.491 | 97.356 | 92.086 | 1.236 | 3.017 | 2.593 | 3.415 | 4.05 | 3.963 |
| Total Non-Current Assets
| 2,231.46 | 2,120.168 | 1,754.45 | 1,230.059 | 934.918 | 746.716 | 471.741 | 300.666 | 288.489 | 228.093 | 161.803 | 87.004 | 35.411 |
| Total Assets
| 5,543.302 | 5,413.416 | 4,810.102 | 3,216.67 | 2,494.662 | 2,051.958 | 1,702.4 | 1,299.867 | 688.675 | 539.013 | 461.727 | 341.579 | 246.241 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 135.623 | 128.522 | 60.76 | 50.216 | 32.831 | 29.897 | 25.646 | 19.949 | 28.407 | 9.788 | 5.882 | 6.514 | 4.639 |
| Short Term Debt
| 261.83 | 317.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 57.408 | 51.006 | 105.691 | 95.896 | 41.513 | 41.059 | 36.755 | 29.371 | 29.156 | 15.909 | 18.187 | 13.807 | 10.885 |
| Deferred Revenue
| 0 | 42.298 | 319.95 | 26.948 | 7.389 | 2.491 | 1.675 | 1.028 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 374.558 | 220.564 | 199.16 | 184.704 | 188.289 | 207.942 | 207.443 | 34.967 | 31.593 | 27.921 | 29.222 | 16.629 | 13.002 |
| Total Current Liabilities
| 829.42 | 717.182 | 386.26 | 330.817 | 262.633 | 278.899 | 269.843 | 84.286 | 89.157 | 53.618 | 53.29 | 36.951 | 28.526 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 1,392.449 | 954.127 | 914.383 | 11.766 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 151.783 | 151.656 | 125.084 | 51.699 | 60.68 | 51.143 | 41.06 | 31.525 | 35.454 | 32.972 | 28.312 | 13.789 | 2.15 |
| Deferred Tax Liabilities Non-Current
| 16.776 | 936.783 | 0.729 | 0.544 | 0.815 | 0.584 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 154.778 | 125.084 | -11.766 | 0 | -0.584 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 1,561.007 | 1,105.783 | 1,040.197 | 52.244 | 61.494 | 51.143 | 41.06 | 31.525 | 35.454 | 32.972 | 28.312 | 13.789 | 2.15 |
| Total Liabilities
| 2,390.427 | 1,822.965 | 1,426.457 | 383.06 | 324.127 | 330.042 | 310.904 | 115.812 | 124.611 | 86.59 | 81.602 | 50.74 | 30.676 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 5.001 | 0 | 0 | 0 | 0 | 17.384 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 807.555 | 807.71 | 805.497 | 799.109 | 418.663 | 417.276 | 416.604 | 412 | 370 | 370 | 135 | 75 | 75 |
| Retained Earnings
| 2,003.919 | 2,102.661 | 1,933.268 | 1,367.793 | 958.67 | 696.619 | 481.617 | 308.81 | 126.875 | 35.374 | 210.113 | 133.507 | 68.235 |
| Accumulated Other Comprehensive Income/Loss
| 550.716 | -5.001 | 30.594 | 330.966 | 185.253 | 65.975 | -17.384 | 87.246 | 67.188 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| -214.715 | 149.23 | 589.499 | 636.804 | 765.136 | 584.583 | 475.483 | 463.245 | 67.188 | 0.126 | 35.012 | 82.333 | 72.331 |
| Total Shareholders Equity
| 3,147.475 | 3,574.282 | 3,358.858 | 2,806.79 | 2,142.47 | 1,698.479 | 1,391.088 | 1,184.055 | 564.064 | 452.423 | 380.124 | 290.84 | 215.566 |
| Total Equity
| 3,152.875 | 3,590.451 | 3,383.646 | 2,833.61 | 2,170.535 | 1,721.916 | 1,391.497 | 1,184.055 | 564.064 | 452.423 | 380.124 | 290.84 | 215.566 |
| Total Liabilities & Shareholders Equity
| 5,543.302 | 5,413.416 | 4,810.102 | 3,216.67 | 2,494.662 | 2,051.958 | 1,702.4 | 1,299.867 | 688.675 | 539.013 | 461.727 | 341.579 | 246.241 |